0000899243-21-024236.txt : 20210616
0000899243-21-024236.hdr.sgml : 20210616
20210616184644
ACCESSION NUMBER: 0000899243-21-024236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gall Matthew
CENTRAL INDEX KEY: 0001816194
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 211022776
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-16
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816194
Gall Matthew
C/O ITEOS THERAPEUTICS, INC., 139
MAIN STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2021-06-16
4
P
0
5000
26.0893
A
5000
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.84 to $26.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
/s/ Michel Detheux, as Attorney-in-Fact
2021-06-16